| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/J.GASTRO.2004.07.009 |
| P698 | PubMed publication ID | 15480989 |
| P2093 | author name string | Shinji Tanaka | |
| Jack R Wands | |||
| Michael C Kew | |||
| Miran Kim | |||
| Suzanne de la Monte | |||
| Philippe Merle | |||
| Christian Trepo | |||
| Annette Von Dem Bussche | |||
| Marc Herrmann | |||
| P2860 | cites work | Infection of a human hepatoma cell line by hepatitis B virus | Q34388628 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | overexpression | Q61643320 |
| P304 | page(s) | 1110-1122 | |
| P577 | publication date | 2004-10-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. | |
| P478 | volume | 127 |
| Q26739665 | A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers |
| Q51075189 | A novel therapeutic drug for colon cancer: EpCAM scFv-truncated protamine (tp)-siRNA. |
| Q28079789 | Aberrant regulation of Wnt signaling in hepatocellular carcinoma |
| Q36386273 | Activation of signal transduction pathways during hepatic oncogenesis |
| Q37177897 | An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET). |
| Q37336447 | Analysis of cellular changes resulting from forced expression of Dickkopf-1 in hepatocellular carcinoma cells |
| Q53602402 | Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray. |
| Q37222630 | Anti-insulin-like growth factor-IIP3 DNAzymes inhibit cell proliferation and induce caspase-dependent apoptosis in human hepatocarcinoma cell lines |
| Q24647547 | Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression |
| Q39254272 | Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma. |
| Q34630557 | Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. |
| Q24318355 | Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells |
| Q37630181 | Cancer stem cells and hepatocellular carcinoma |
| Q36793453 | Cancer stem cells in the development of liver cancer |
| Q93004356 | Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside |
| Q47436909 | Cellular and molecular mechanisms underlying planar cell polarity pathway contributions to cancer malignancy |
| Q37622144 | Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver disease. |
| Q36755188 | Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma |
| Q34442738 | Comparison of the regulation of β-catenin signaling by type I, type II and type III interferons in hepatocellular carcinoma cells |
| Q53708414 | Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway. |
| Q37291356 | Crosstalk between beta-catenin and snail in the induction of epithelial to mesenchymal transition in hepatocarcinoma: role of the ERK1/2 pathway |
| Q35546735 | Depletion of β-catenin from mature hepatocytes of mice promotes expansion of hepatic progenitor cells and tumor development |
| Q48526220 | Deregulation of Frizzled Receptors in Hepatocellular Carcinoma. |
| Q28391394 | Dickkopfs and Wnt/β-catenin signalling in liver cancer |
| Q24317793 | Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells |
| Q55380301 | Downregulation of Frizzled-7 induces the apoptosis of hepatocellular carcinoma cells through inhibition of NF-κB. |
| Q38210247 | Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma. |
| Q37966605 | Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers |
| Q36519010 | Dysregulation of growth factor signaling in human hepatocellular carcinoma. |
| Q34081570 | Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells |
| Q91895963 | Expression of LGR5, FZD7, TROY, and MIST1 in Perioperatively Treated Gastric Carcinomas and Correlation with Therapy Response |
| Q36082608 | FZD6 expression is negatively regulated by miR-199a-5p in human colorectal cancer |
| Q34007808 | FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway. |
| Q42371598 | FZD7 is a novel prognostic marker and promotes tumor metastasis via WNT and EMT signaling pathways in esophageal squamous cell carcinoma |
| Q45912883 | Frizzled 8 promotes the cell proliferation and metastasis of renal cell carcinoma. |
| Q38717343 | Frizzled gene expression and negative regulation of canonical WNT-β-catenin signaling in mouse F9 teratocarcinoma cells. |
| Q27010132 | Frizzled homolog proteins, microRNAs and Wnt signaling in cancer |
| Q36730947 | Frizzled-7 as a potential therapeutic target in colorectal cancer |
| Q36545508 | Frizzled-7 promoter is highly active in tumors and promoter-driven Shiga-like toxin I inhibits hepatocellular carcinoma growth |
| Q28242018 | Frizzled-7 turnover at the plasma membrane is regulated by cell density and the Ca(2+) -dependent protease calpain-1 |
| Q26849278 | Frizzled7 as an emerging target for cancer therapy |
| Q26747651 | Frizzled7: A Promising Achilles' Heel for Targeting the Wnt Receptor Complex to Treat Cancer |
| Q36415111 | Functional consequences of WNT3/Frizzled7-mediated signaling in non-transformed hepatic cells |
| Q24320123 | Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells |
| Q54458047 | Genetic inactivation of the APC gene contributes to the malignant progression of sporadic hepatocellular carcinoma: a case report. |
| Q80353336 | Genetics of hepatocellular carcinoma |
| Q82640093 | Hepatic adenomas: presumed innocent until proven to be beta-catenin mutated |
| Q39588175 | Hepatitis C virus core protein activates Wnt/β-catenin signaling through multiple regulation of upstream molecules in the SMMC-7721 cell line |
| Q36414367 | Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes |
| Q36561567 | Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies |
| Q64955766 | Hepatocyte Wnts Are Dispensable During Diethylnitrosamine and Carbon Tetrachloride-Induced Injury and Hepatocellular Cancer. |
| Q34732789 | Identification of T-cell factor-4 isoforms that contribute to the malignant phenotype of hepatocellular carcinoma cells |
| Q37809668 | International Union of Basic and Clinical Pharmacology. LXXX. The Class Frizzled Receptors |
| Q92827361 | Isolation and characterization of a new basal-like luminal progenitor in human breast tissue |
| Q26799745 | Klotho: a tumor suppressor and modulator of the Wnt/β-catenin pathway in human hepatocellular carcinoma |
| Q37358938 | Liver stem cells and hepatocellular carcinoma |
| Q43148137 | Liver stem cells and molecular signaling pathways in hepatocellular carcinoma |
| Q58699397 | Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/β-catenin signal pathway in hepatocellular carcinoma |
| Q36996036 | Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells |
| Q37179096 | Loss of exon 4 in a human T-cell factor-4 isoform promotes hepatic tumourigenicity |
| Q34328494 | Loss of the SxxSS motif in a human T-cell factor-4 isoform confers hypoxia resistance to liver cancer: an oncogenic switch in Wnt signaling |
| Q91893596 | Mesenchymal stromal cells induce inhibitory effects on hepatocellular carcinoma through various signaling pathways |
| Q92512198 | MicroRNA-206 attenuates glioma cell proliferation, migration, and invasion by blocking the WNT/β-catenin pathway via direct targeting of Frizzled 7 mRNA |
| Q24312971 | Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis |
| Q35260040 | Molecular mechanisms underlying hepatocellular carcinoma |
| Q26745338 | Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances |
| Q38475203 | Molecular signalling in hepatocellular carcinoma: Role of and crosstalk among WNT/ß-catenin, Sonic Hedgehog, Notch and Dickkopf-1. |
| Q37847073 | Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies |
| Q35541482 | Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview |
| Q36519041 | New therapies for hepatocellular carcinoma. |
| Q24297486 | Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration |
| Q34940971 | Novel therapeutic strategies for targeting liver cancer stem cells |
| Q37438352 | Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2. |
| Q33298434 | Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways. |
| Q37013296 | Overexpression of hepatocyte nuclear factor 4α in human mesenchymal stem cells suppresses hepatocellular carcinoma development through Wnt/β-catenin signaling pathway downregulation |
| Q28246572 | Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver |
| Q40203803 | PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. |
| Q39635094 | Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma |
| Q36157238 | Pigment Epithelium-Derived Factor (PEDF) Inhibits Wnt/β-catenin Signaling in the Liver |
| Q38111369 | Planar cell polarity signaling in collective cell movements during morphogenesis and disease |
| Q53297765 | Pre-"EMT"ing key processes in liver carcinogenesis: Growing evidence for how malignant hepatocytes invade and conquer. |
| Q55033899 | Precision medicine based on surgical oncology in the era of genome-scale analysis and genome editing technology. |
| Q39635505 | Prognostic value of Wnt inhibitory factor-1 expression in hepatocellular carcinoma that is independent of gene methylation. |
| Q40263391 | Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma |
| Q24669950 | R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells |
| Q28484499 | Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system |
| Q36517050 | Repair and regeneration: opportunities for carcinogenesis from tissue stem cells |
| Q33940403 | Role of Wnt/β-catenin signaling in liver metabolism and cancer |
| Q24309164 | SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway |
| Q24303537 | SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway |
| Q38719559 | Short hairpin RNA silencing of TGF-βRII and FZD-7 synergistically suppresses proliferation and metastasis of hepatocellular carcinoma cells |
| Q40262786 | Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties |
| Q36455499 | Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma |
| Q24292953 | Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin |
| Q34157590 | Stage of breast cancer progression influences cellular response to activation of the WNT/planar cell polarity pathway |
| Q36381984 | Structure-based Discovery of Novel Small Molecule Wnt Signaling Inhibitors by Targeting the Cysteine-rich Domain of Frizzled |
| Q92511198 | Structure-guided design fine-tunes pharmacokinetics, tolerability, and antitumor profile of multispecific frizzled antibodies |
| Q41547180 | Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells |
| Q27002288 | Targeted therapy for hepatocellular carcinoma: novel agents on the horizon |
| Q53394852 | The expression and function of Frizzled-7 in human renal cell carcinoma. |
| Q27003050 | The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update |
| Q37873514 | Therapeutic potential of targeting glypican-3 in hepatocellular carcinoma |
| Q34263359 | Upregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasion |
| Q34568619 | Viral hepatitis and liver cancer: the case of hepatitis C. |
| Q36804161 | WNT/beta-catenin signaling in liver health and disease |
| Q87469831 | WNT/β-catenin signaling and hepatocellular carcinoma |
| Q35093167 | WNTS and WNT receptors as therapeutic tools and targets in human disease processes. |
| Q35659072 | Wnt signaling in liver cancer |
| Q91643281 | Wnt signaling in liver disease: emerging trends from a bibliometric perspective |
| Q51998552 | Wnt'er in liver: expression of Wnt and frizzled genes in mouse. |
| Q36247123 | Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. |
| Q37080175 | Wnt/beta-catenin signaling in hepatic organogenesis |
| Q38290485 | Wnt9a secreted from the walls of hepatic sinusoids is essential for morphogenesis, proliferation, and glycogen accumulation of chick hepatic epithelium |
| Q39418588 | Zinc finger transcription factor 191, directly binding to β-catenin promoter, promotes cell proliferation of hepatocellular carcinoma. |
| Q36143616 | siRNA-mediated beta-catenin knockdown in human hepatoma cells results in decreased growth and survival |
| Q28087660 | β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis |
Search more.